Sky Medical Technology Ltd
- Industry
- Medical Devices & Equipment
- Founded Year
- 2006
- Headquarters
- High Wycombe, United Kingdom
- Employee Count
- 48
Key People
- Bernard Ross - CEO and Founder
- Ron Long - Board Member
- Edward Rudd - Board Member
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team, led by CEO and Founder Bernard Ross, comprises experienced professionals with a track record in the MedTech industry.
A team with multiple successful MedTech entrepreneurs brings valuable industry insights, networks, and strategic direction, enhancing the company's potential for success.
- Clinical Need
-
Aspect: Very Strong
Summary: The company's products address critical circulatory conditions, including life-threatening blood clots and chronic wounds.
Targeting severe circulatory conditions with high morbidity and mortality rates ensures a strong clinical need, driving demand for effective solutions.
- Competition
-
Aspect: Somewhat crowded
Summary: The market for circulatory condition treatments includes several established players, though Sky Medical's bioelectronic approach offers differentiation.
A somewhat crowded market indicates competition, but innovative technologies can carve out significant market share by offering superior or novel solutions.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing bioelectronic devices involves moderate technical challenges, including ensuring efficacy, safety, and regulatory compliance.
Moderate technical challenges require robust R&D and quality assurance processes but are manageable with experienced teams and adequate resources.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents for its OnPulse technology, providing a competitive advantage.
Robust patents safeguard intellectual property, deter competitors, and can be leveraged for strategic partnerships or licensing opportunities.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors, supporting its growth and development initiatives.
Sufficient financing ensures resources are available for R&D, regulatory processes, and market expansion, which are critical for success in the MedTech sector.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's products have obtained necessary regulatory approvals, facilitating market entry.
Achieving regulatory clearance is a significant milestone, allowing the company to market its products and generate revenue while ensuring compliance with health standards.
Opportunity Rollup
- Odds of Success
- 3.4
- Peak Market Share
- 4.3
- Segment CAGR
- 5.4%
- Market Segment
- Medical Devices & Equipment
- Market Sub Segment
- Bioelectronic Medicine
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.22 |
| 2 | 0.64 |
| 3 | 1.50 |
| 4 | 3.01 |
| 5 | 4.30 |
Key Takeaway
Sky Medical Technology, with its innovative bioelectronic devices, is well-positioned to address significant clinical needs in circulatory health, supported by a strong team and solid financial backing.